PCSK9 Inhibitors

Nisha K. Patel, PharmD, MBA, BCPS, Saira Khan, M.D., Alona Crowder, Pharm.D.
PCSK9 Inhibitors is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

To be used as an adjunct to diet and maximally tolerated statin therapy in:

  • Adult patients with heterozygous familial hypercholesterolemia
  • Adult patients with homozygous familial hypercholesterolemia
  • Patients with clinical atherosclerotic cardiovascular disease who require additional LDL lowering

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

To be used as an adjunct to diet and maximally tolerated statin therapy in:

  • Adult patients with heterozygous familial hypercholesterolemia
  • Adult patients with homozygous familial hypercholesterolemia
  • Patients with clinical atherosclerotic cardiovascular disease who require additional LDL lowering

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: October 4, 2020